HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sahani, D. V. Articles by Lee, T.-Y. Search for Related Content PubMed PubMed Citation Articles by Sahani, D. V. Articles by Lee, T.-Y.

Assessing Tumor Perfusion and Treatment Response in Rectal Cancer with Multisection CT: Initial Observations¹

¹ From the Division of Abdominal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, 55 Fruit St, White 270 F, Boston, MA 02114. From the 2003 RSNA Annual Meeting. Received February 13, 2004; revision requested April 15; revision received May 13; accepted June 15. Address correspondence to D.V.S. (e-mail: dsahani@partners.org).

PURPOSE: To use first-pass perfusion computed tomography (CT) to prospectively investigate tumor vascularity in rectal cancer and to determine whether any of the perfusion parameters would predict tumor response to chemotherapy and radiation therapy.

MATERIALS AND METHODS: The institutional review board approved this study, and informed prior consent was obtained from participants. Perfusion CT of rectal cancer was performed with four-section multi–detector row CT in 15 patients (13 men, two women; mean age, 62.1 years; age range, 46–84 years). Five patients with prostate cancer served as controls. All patients with rectal cancer underwent 6–8 weeks of chemotherapy and radiation therapy followed by surgery. In nine patients, perfusion CT was repeated after completion of chemotherapy and radiation therapy. Contrast medium–enhanced dynamic CT was performed with a static table position for 45 seconds, and the data were analyzed by using commercial software to calculate tissue blood flow (BF), blood volume, mean transit time (MTT), and vascular permeability–surface area product. Perfusion parameters of normal rectum and tumor were compared. Perfusion parameters before and after chemotherapy and radiation therapy were compared. A tumor was considered to have responded if its stage at pathologic analysis indicated regression compared with the preoperative stage. Baseline perfusion values were compared between responders and nonresponders. Statistical analysis was performed with the Student t test.

RESULTS: Rectal cancer showed higher BF and shorter MTT compared with those of normal rectum (P .05). After chemotherapy and radiation therapy, tumors showed significant reduction in BF and increase in MTT (P .05). There was a significant difference in baseline BF and MTT values between responders and nonresponders (P .05). Tumors in three patients with high initial BF and short MTT showed poor response.

CONCLUSION: Perfusion CT of rectal cancer can enable assessment of tumor vascularity and perfusion changes that result from chemotherapy and radiation therapy. In this small patient sample, tumors with initial high BF and short MTT values tended to respond poorly to chemotherapy and radiation therapy.

© RSNA, 2005

This article has been cited by other articles:

				A. Sabir, R. Schor-Bardach, C. J. Wilcox, S. Rahmanuddin, M. B. Atkins, J. B. Kruskal, S. Signoretti, V. D. Raptopoulos, and S. N. Goldberg Perfusion MDCT Enables Early Detection of Therapeutic Response to Antiangiogenic Therapy Am. J. Roentgenol., July 1, 2008; 191(1): 133 - 139. [Abstract] [Full Text] [PDF]

				V. Goh, S. Halligan, A. Gharpuray, D. Wellsted, J. Sundin, and C. I. Bartram Quantitative Assessment of Colorectal Cancer Tumor Vascular Parameters by Using Perfusion CT: Influence of Tumor Region of Interest Radiology, June 1, 2008; 247(3): 726 - 732. [Abstract] [Full Text] [PDF]

				D. L. Buckley, V. Goh, and S. Halligan Are Measurements from Two Commercial Software Packages Interchangeable? Possibly, If Like Is Compared with Like Radiology, February 1, 2008; 246(2): 642 - 643. [Full Text] [PDF]

				R. G. Sheiman, A. Sitek, V. Goh, and S. Halligan CT Perfusion Imaging: Know Its Assumptions and Limitations Radiology, February 1, 2008; 246(2): 649 - 650. [Full Text] [PDF]

				A. X. Zhu, N. S. Holalkere, A. Muzikansky, K. Horgan, and D. V. Sahani Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular Carcinoma Oncologist, February 1, 2008; 13(2): 120 - 125. [Abstract] [Full Text] [PDF]

				S. C. Faria, C. S. Ng, K. R. Hess, S. Phongkitkarun, J. Szejnfeld, D. Daliani, and C. Charnsangavej CT Quantification of Effects of Thalidomide in Patients with Metastatic Renal Cell Carcinoma Am. J. Roentgenol., August 1, 2007; 189(2): 378 - 385. [Abstract] [Full Text] [PDF]

				M. Bellomi, G. Petralia, A. Sonzogni, M. G. Zampino, and A. Rocca CT Perfusion for the Monitoring of Neoadjuvant Chemotherapy and Radiation Therapy in Rectal Carcinoma: Initial Experience Radiology, August 1, 2007; 244(2): 486 - 493. [Abstract] [Full Text] [PDF]

				A. Hakime, H. Peddi, A. U. Hines-Peralta, C. J. Wilcox, J. Kruskal, S. Lin, T. de Baere, V. D. Raptopoulos, and S. N. Goldberg CT Perfusion for Determination of Pharmacologically Mediated Blood Flow Changes in an Animal Tumor Model Radiology, June 1, 2007; 243(3): 712 - 719. [Abstract] [Full Text] [PDF]

				D. V. Sahani, N.-S. Holalkere, P. R. Mueller, and A. X. Zhu Advanced Hepatocellular Carcinoma: CT Perfusion of Liver and Tumor Tissue--Initial Experience Radiology, June 1, 2007; 243(3): 736 - 743. [Abstract] [Full Text] [PDF]

				J. M. Provenzale Imaging of Angiogenesis: Clinical Techniques and Novel Imaging Methods Am. J. Roentgenol., January 1, 2007; 188(1): 11 - 23. [Abstract] [Full Text] [PDF]

				V Goh, S Halligan, L Gartner, P Bassett, and C I Bartram Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility? Br. J. Radiol., July 1, 2006; 79(943): 578 - 583. [Abstract] [Full Text] [PDF]

				M. K. Kalra, W. C. Small, and W. E. Torres A 45-Second CT Perfusion Protocol for Rectal Cancers May Not Be Adequate to Infer Vascular Permeability-Surface Area Products Radiology, February 1, 2006; 238(2): 755 - 756. [Full Text] [PDF]

				C. Kremser, T. R. Trieb, W. Judmaier, A. F. DeVries, D. Sahani, S. Kalva, and P. F. Hahn Assessing Tumor Perfusion and Treatment Response in Rectal Cancer Radiology, February 1, 2006; 238(2): 756 - 757. [Full Text] [PDF]

				D. Sahani, S. Kalva, and P. F. Hahn Response Radiology, February 1, 2006; 238(2): 757 - 757. [Full Text] [PDF]